Open access · CC-BY
via OpenAlex
Sarcopenia in aging, obesity, and cancer
Jennifer A. Ligibel, Kathryn H. Schmitz, Nathan A. Berger
Translational Cancer Research · 2020 · ▲ 55 citations
Abstract
Sarcopenia, defined as loss of muscle mass, strength and physical performance, is a hallmark of aging and is invariably associated with perturbation of amino acid metabolism, increased muscle protein catabolism relative to anabolism, and loss of muscle fibers. Sarcopenia may be associated with general loss of body mass, or it may also occur along with obesity [sarcopenic obesity (SO)]. Although sarcopenia is associated with multiple comorbidities in older adults, its effects may even be more severe in patients with malignant disease where it has been shown to contribute to poor surgical outcomes, increased chemotherapy toxicity associated with both cytotoxic and targeted agents, as well as adversely impacting survival. While development of sarcopenia is a common age-related phenomenon, the associated catabolic processes appear to be promoted by physical inactivity, inadequate nutrition, and systemic low-grade inflammation, as well as intrinsic muscle and molecular changes, including mitochondrial dysfunction(definition) and impaired muscle stem cell regenerative capacity. Increased physical activity and adequate protein intake can reduce incidence and severity of sarcopenia in cancer patients, but many older cancer patients do not meet physical activity and nutrition recommendations, and cancer treatment can make it more difficult to make favorable lifestyle changes. Sarcopenia is discussed in terms of its adverse clinical consequences in older subjects and particularly, in older patients with cancer. Contributions of lifestyle, molecular, and cellular factors are likewise reviewed with suggestions for interventions to improve sarcopenia and its comorbid sequalae.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.21037/tcr-2019-eaoc-05
- Canonical
- link ↗
- Fetched
- 2026-07-31 MST
Cite this
APA
Ligibel, J.A., Schmitz, K.H., & Berger, N.A. (2020). Sarcopenia in aging, obesity, and cancer. <em>Translational Cancer Research</em>. https://doi.org/10.21037/tcr-2019-eaoc-05
Vancouver
Ligibel JA, Schmitz KH, Berger NA. Sarcopenia in aging, obesity, and cancer. Translational Cancer Research. 2020. doi:10.21037/tcr-2019-eaoc-05.
BibTeX
@article{jennifer2020Sarcop,
title = {Sarcopenia in aging, obesity, and cancer},
author = {Jennifer A. Ligibel and Kathryn H. Schmitz and Nathan A. Berger},
journal = {Translational Cancer Research},
year = {2020},
doi = {10.21037/tcr-2019-eaoc-05},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Proceedings of the National Academy of Sciences of the United States of America 2026
Citation only
An integrative transcriptomic atlas of ALS and aging skeletal muscle defines shared and distinct molecular programs of degeneration.
Dokuz Eylul University 2023
Open access · US-GOV
Evaluation of Sarcopenia and Associated Factors in Patients With Lipedema
Medicina (Kaunas, Lithuania) 2026
Citation only
Sex-Specific Associations Between Sarcopenia and Obesity Parameters and Falls in Korean Older Adults: A Cross-Sectional Analysis of the Korean Frailty and Aging Cohort Study.
UNC Lineberger Comprehensive Cancer Center 2014
Open access · US-GOV
LCCC 1410: Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older
The journal of nutrition health & aging 2024
Open access · CC-BY
Mitochondrial pathways and sarcopenia in the geroscience era
Mersin University 2024
Open access · US-GOV